DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit After Tax | ₹2,960 Cr | ₹1,984 Cr | ₹1,377 Cr | ₹1,353 Cr | ₹877 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
Year | Profit After Tax |
---|---|
Mar2023 | ₹2,960 Cr |
Mar2022 | ₹1,984 Cr |
Mar2021 | ₹1,377 Cr |
Mar2020 | ₹1,353 Cr |
Mar2019 | ₹877 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹2,960 Cr | 49.19 | |
Mar2022 | ₹1,984 Cr | 44.15 | |
Mar2021 | ₹1,377 Cr | 1.76 | |
Mar2020 | ₹1,353 Cr | 54.24 | |
Mar2019 | ₹877 Cr | - |
Compare Profit After Tax of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹103,857.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics | |
MANKIND PHARMA | ₹88,830.5 Cr | -6.3% | -5% | NA | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.2% |
6.2% |
21.2% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses